All In Biotech

Drug Trial Radar · NCT01956123

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2

A Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Evaluating the Immunogenicity of FE 999049 in Repeated Cycles of Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme

Last checked: Nov 19, 2026Latest source record: Sep 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

513

Actual

Start

Mar 26, 2014

Primary completion

May 2015

Study completion Jan 3, 2017

Sponsor

Lead sponsor
Ferring PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Oct 8, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
Who can join
Female only, from 18 years, up to 40 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This trial investigates the immunogenicity of FE 999049 in repeated cycles.

Conditions

  • Infertility

Interventions

  • Follitropin Delta (FE 999049)Drug

  • Follitropin Alfa (GONAL-F)Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion (Percentage) of Subjects With Treatment-induced Anti-Follicle-Stimulating Hormone (FSH) Antibodies After up to Two Repeated Controlled Ovarian Stimulation CyclesTime frame: Stimulation day 1, 7-10 days after last FE 999049 or GONAL-F dose and 21-28 days after last FE 999049 or GONAL-F dose

Locations

13 sites in 11 countries. Site status is shown where the registry gives one.

  • UZ Brussel (there may be other sites in this country)

    Brussels, Belgium

  • Fertilitat and PUC-RS (there may be other sites in this country)

    Porto Alegre, Brazil

  • Pacific Centre for Reproductive Medicine

    Burnaby, British Columbia, Canada

  • Olive Fertility Centre

    Vancouver, British Columbia, Canada

  • Ottawa Fertility Centre

    Ottawa, Ontario, Canada

  • IVF CUBE SE (there may be other sites in this country)

    Prague, Czechia

  • Rigshospitalet Fertilitetsklinikken (there may be other sites in this country)

    Copenhagen, Denmark

  • Department of Endocrine Gynaecology and Reproductive Medicine, Hôpital Jeanne de Flandre (there may be other sites in this country)

    Lille, France

  • Centro Natalità San Raffaele (there may be other sites in this country)

    Milan, Italy

  • The nOvum Clinic (there may be other sites in this country)

    Warsaw, Poland

  • IVF & Reproductive Genetics Center (there may be other sites in this country)

    Moscow, Russia

  • IVI Sevilla (there may be other sites in this country)

    Seville, Spain

  • Glasgow Centre for Reproductive Medicine Ltd. (there may be other sites in this country)

    Glasgow, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.